Brief: Pharmesis International Says Unit Entered Conditional Sale And Purchase Agreement
23/09/2024 14:17
Sept 23 (Reuters) - Pharmesis International Ltd
PHAR.SI :
* UNIT ENTERED CONDITIONAL SALE AND PURCHASE AGREEMENT
* AGGREGATE PURCHASE CONSIDERATION OF RMB2.8 MILLION
* AGREEMENT TO ACQUIRE REMAINING 19% EQUITY INTEREST IN
SICHUAN
LONGLIFE PHARMACEUTICAL
Further company coverage: PHAR.SI
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pharmesis International
See all newsPharmesis H1 revenue falls 56% amid challenging operating environment
Brief: Pharmesis International Sees Net Loss For HY
Brief: Pharmesis International Says Proposing To Undertake Capital Reduction Exercise
Brief: Pharmesis International Sees Net Profit For 6M & FY Ended 31 Dec 2024
Brief: Pharmesis International Says Unit Entered Conditional Sale And Purchase Agreement